Palliative Nd:YAG laser therapy for cancer of the esophagus and gastroesophageal junction: impact on the quality of remaining life

Rutgeerts, Paul; Vantrappen, Gaston; Broeckaert, L; Muls, M; Geboes, Karel; Coremans, Georges; Janssens, J

doi:10.1016/s0016-5107(88)71269-9

Cited by 59 publications

(16 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The risk for perforation is reported to increase by 1 to 10% with repeated treatment (6). Also, with laser treatment alone the dysphagia-free interval is limited to a few weeks only (2,17,18).…”

Section: Discussionmentioning

confidence: 99%

Laser Therapy and Insertion of Wallstents for Palliative Treatment of Esophageal Carcinoma

et al. 1991

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Laser Therapy and Insertion of Wallstents for Palliative Treatment of Esophageal Carcinoma

et al. 1991

View full text Add to dashboard Cite

show abstract

“…ing of macrobiopsies, laser mucosal ablation and coagulation (up to 6%) and the treatment of varices (3)(4)(5)(6)(7). In addition, several procedures can induce bleeding that is difficult or impossible to control endoscopically: bougienage or pneumatic dilation of strictures, EUS-guided fine-needle aspiration or therapy, cyst-enterostomy and percutaneous endoscopic gastrostomy.…”

Section: Focus On Endoscopymentioning

confidence: 99%

Management of Anticoagulants before and after Endoscopy

Hittelet

Devière

2003

Canadian Journal of Gastroenterology

View full text Add to dashboard Cite

“…Therefore, in assessing the merit of ELT, it is important to take into account matters such as quality of life and cost. Rutgeerts et al [38] evaluated the impact of palliative ELT for esophageal cancer on quality of remaining life. In 30% of the patients treated, Iaser therapy was the only palliative option available, and in seven of nine, a fair functional success was achieved.…”

Section: Clinical Datamentioning

confidence: 99%

Endoscopic laser therapy for esophageal cancer: Present status with emphasis on past and future

Fleischer

1989

Lasers Surg Med

View full text Add to dashboard Cite

Although the major initial application for endoscopic laser therapy was for the management of gastrointestinal hemorrhage, it is now more common to use the laser endoscopically for the treatment of gastrointestinal neoplasms. A major body of literature surrounds the use of endoscopic laser therapy for esophageal cancer. The initial patient evaluation to determine if laser therapy is indicated includes a contrast radiograph, a screening endoscopy, and an imaging study. After these tests have been performed, it can be determined whether endoscopic laser therapy (ELT) is the best of the many endoscopic options. There is some difference of opinion as to the specifics of the treatment technique, and these are described. There is general agreement from reviewing the clinical data that it is possible to open the obstructed lumen in a large majority of cases and that functional success (the ability to achieve technically good results as well as clinical improvement without complications) is also possible in the majority of patients. Despite the information suggesting the benefits of ELT for esophageal cancer, there are both conceptual and technical limitations to the current approach to therapy. These limitations as well as potential future applications are discussed.

show abstract

Palliative Nd:YAG laser therapy for cancer of the esophagus and gastroesophageal junction: impact on the quality of remaining life

Cited by 59 publications

References 6 publications

Laser Therapy and Insertion of Wallstents for Palliative Treatment of Esophageal Carcinoma

Laser Therapy and Insertion of Wallstents for Palliative Treatment of Esophageal Carcinoma

Management of Anticoagulants before and after Endoscopy

Endoscopic laser therapy for esophageal cancer: Present status with emphasis on past and future

Contact Info

Product

Resources

About